Investing.com - Financial Markets Worldwide

Abrdn life sciences investors HQL: Weinstein sells $329k in shares

Published 02/09/2025, 19:44
Abrdn life sciences investors HQL: Weinstein sells $329k in shares
HQL
-0.48%

Boaz Weinstein, a ten percent owner, reported selling 23,723 shares of abrdn Life Sciences Investors NASDAQ:HQL common stock on August 29, 2025. The shares were sold at a price of $13.89, for a total transaction value of $329,512. The stock, currently trading at $14.00, has shown strong momentum with a 17.36% return year-to-date. Notable for income investors, HQL offers a substantial 12.04% dividend yield.

Following the transaction, Saba Capital Management, L.P. and Boaz Weinstein, indirectly own 2,982,706 shares of abrdn Life Sciences Investors. The company, with a market capitalization of $404 million, has maintained dividend payments for 30 consecutive years. InvestingPro analysis reveals several more key insights about HQL’s dividend sustainability and financial health.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.